# Gastric Cancer

> A malignant tumor arising from the gastric epithelium, commonly affecting the antrum and lesser curvature.

## Classification

### 1. Based on Histology (WHO Classification)

1. `Adenocarcinoma` (90%) → Most common type
   - **Intestinal type** → Well-differentiated, associated with _H. pylori_, better prognosis
   - **Diffuse type** → Poorly differentiated, signet ring cells, _E-cadherin mutation_, worse prognosis
1. `Lymphoma` → MALT lymphoma (associated with _H. pylori_)
1. `Gastrointestinal stromal tumor (GIST)` → From interstitial cells of Cajal
1. `Neuroendocrine tumors (Carcinoid tumors)`
1. `Squamous cell carcinoma` (rare)

### 2. Based on Macroscopic Appearance (Borrmann Classification Endoscopic & Gross Pathology)

| Type       | Description                             |
| ---------- | --------------------------------------- |
| **Type 1** | Polypoid (exophytic)                    |
| **Type 2** | Ulcerated with defined margins          |
| **Type 3** | Ulcerated with infiltrating margins     |
| **Type 4** | Diffuse infiltrative (Linitis plastica) |
| **Type 5** | Unclassifiable                          |

## Pathology

### Pathogenesis

1. **Chronic inflammation** (_H. pylori, autoimmune gastritis_)
2. **Atrophic gastritis** → Intestinal metaplasia
3. **Dysplasia** → Accumulation of mutations
4. **Carcinoma**

### Molecular Pathways

- **Intestinal type** → _APC mutation, TP53 loss, Microsatellite instability (MSI)_
- **Diffuse type** → _CDH1 mutation (E-cadherin loss)_ → Infiltrative growth

### Gross Pathology

- **Intestinal type** → Glandular structures, expanding growth
- **Diffuse type** → `Signet ring cells`, desmoplasia, thickened stomach wall (Linitis plastica)

## Staging of Gastric Cancer (AJCC TNM System)

1. Tumors
   - `T1` → Mucosa/submucosa
   - `T2` → Muscularis propria
   - `T3` → Subserosa
   - `T4` → Infiltrates adjacent organs
1. Nodes
   - `N0` → No LN involvement
   - `N1` → 1-2 LNs
   - `N2` → 3-6 LNs
   - `N3` → ≥7 LNs |
1. Metastasis
   - `M0` → No distant metastasis
   - `M1` → Distant metastasis (liver, peritoneum, ovaries - Krukenberg tumor)

- **Early gastric cancer (EGC)** → Confined to mucosa/submucosa (T1)
- **Advanced gastric cancer (AGC)** → Invades beyond submucosa

## Investigations of Gastric Cancer

### 1. Laboratory Tests

- **CBC** → Anemia (chronic blood loss)
- **LFTs** → Liver metastasis (↑ ALP, ↑ bilirubin)
- **Tumor markers** (for monitoring, not diagnosis)
  - `CEA (Carcinoembryonic antigen)`
  - `CA 19-9`

### 2. Imaging Studies

- **Upper GI Endoscopy + Biopsy** (**Gold Standard**)
  - Direct visualization of mass, ulcer, or thickened mucosa
  - Biopsy confirms **adenocarcinoma**
- **CT Abdomen + Pelvis**
  - Tumor extent, lymph node involvement, metastases
- **Endoscopic Ultrasound (EUS)**
  - Depth of invasion (T staging)
- **PET-CT**
  - Detects distant metastases
- **Barium Meal X-ray** (if endoscopy unavailable)
  - "Leather bottle stomach" (Linitis plastica)

### 3. Staging Investigations

- **Diagnostic laparoscopy** → Peritoneal metastasis detection
- **Peritoneal cytology** → Micrometastases

## Management

1. **Surgery** (Only curative option for localized disease)
1. **Chemotherapy** (Neoadjuvant, adjuvant, or palliative)
1. **Radiotherapy** (Adjuvant or palliative)
1. **Palliative care** (If unresectable/metastatic)

### Surgical Treatment

#### A. Curative Surgery (For Resectable Tumors)

| Procedure                        | Description                                                                                                                 | Indications                                         | Contraindications                             | Complications                                           |
| -------------------------------- | --------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------- | --------------------------------------------- | ------------------------------------------------------- |
| **Distal Gastrectomy**           | Removal of **distal 2/3 of stomach** with Billroth I (gastroduodenostomy) or Billroth II (gastrojejunostomy) reconstruction | `Distal gastric cancer (antrum, pylorus)`           | Proximal tumors, distant metastases           | Dumping syndrome, bile reflux, anastomotic leak         |
| **Total Gastrectomy**            | Removal of **entire stomach** with Roux-en-Y esophagojejunostomy                                                            | `Proximal/mid gastric cancer`, **Linitis plastica** | Poor general condition, widespread metastases | Nutritional deficiencies, anastomotic leak, esophagitis |
| **Subtotal Gastrectomy**         | Removal of **80% of the stomach**                                                                                           | Selected cases of **distal** gastric cancer         | Proximal tumors                               | Similar to distal gastrectomy                           |
| **Radical (D2) Lymphadenectomy** | Removal of **D1 (perigastric) & D2 (celiac, splenic, hepatic nodes)**                                                       | **Standard for curative intent**                    | If patient cannot tolerate extensive surgery  | Increased surgical risk (bleeding, pancreatic injury)   |

#### B. Palliative Surgery (For Unresectable or Metastatic Disease)

| Procedure                        | Description                                                           | Indications                                        | Contraindications                           | Complications                              |
| -------------------------------- | --------------------------------------------------------------------- | -------------------------------------------------- | ------------------------------------------- | ------------------------------------------ |
| **Palliative Gastrojejunostomy** | Bypass obstruction by creating a gastrojejunostomy                    | `GOO due to advanced gastric cancer`               | If patient is too frail for surgery         | Anastomotic leak, delayed gastric emptying |
| **Palliative Total Gastrectomy** | Removes stomach in patients with severe symptoms but **not curative** | Selected patients with **bleeding or obstruction** | Poor prognosis, extensive peritoneal spread | Similar to total gastrectomy               |
| **Endoscopic Stenting**          | Placement of a **metallic stent** to relieve obstruction              | `Gastric outlet obstruction` (inoperable cases)    | NA                                          | Stent migration, occlusion                 |

### Chemotherapy & Radiotherapy

- **Neoadjuvant Chemotherapy** (Before surgery)
  - Used for **locally advanced tumors** to shrink tumor size
  - **Drugs:** _FLOT regimen (5-FU, Leucovorin, Oxaliplatin, Docetaxel)_
- **Adjuvant Chemotherapy** (After surgery)
  - If **LN metastasis** or **high-risk features**
  - **Drugs:** Capecitabine + Oxaliplatin
- **Palliative Chemotherapy**
  - For **metastatic disease** (prolongs survival)
  - **Drugs:** 5-FU, Cisplatin, Paclitaxel
- **Radiotherapy**
  - Used as **adjuvant therapy** for locally advanced disease
  - Palliative for **bone pain or bleeding tumors**

## Summary of Gastric Cancer Surgery

| Surgery                          | Curative or Palliative? | Key Points                                     |
| -------------------------------- | ----------------------- | ---------------------------------------------- |
| **Distal Gastrectomy**           | Curative                | Used for **distal** tumors                     |
| **Total Gastrectomy**            | Curative                | Used for **proximal** tumors, Linitis plastica |
| **Radical (D2) Lymphadenectomy** | Curative                | Removes perigastric + celiac LNs               |
| **Palliative Gastrojejunostomy** | Palliative              | Relieves **gastric outlet obstruction**        |
| **Endoscopic Stenting**          | Palliative              | For inoperable **gastric obstruction**         |

---

<details>
<summary>Dumping Syndrome</summary>

> A condition that occurs when food moves too quickly from the stomach to the small intestine, leading to rapid gastric emptying. It is a common complication after gastrectomy or gastric bypass surgery.

1. Early Dumping Syndrome (Within 30 minutes of eating)
   - Cause: Rapid influx of hyperosmolar food into the small intestine → Fluid shift from plasma to intestines → Hypovolemia and gut hormone release
   - Symptoms: Abdominal pain, bloating, Diarrhea, Tachycardia, palpitations, Sweating, dizziness
1. Late Dumping Syndrome (1-3 hours after eating)
   - Cause: Rapid glucose absorption → Excessive insulin release → Reactive hypoglycemia
   - Symptoms: Weakness, fatigue, Sweating, tremors, Confusion, syncope

</details>
